Technology | September 18, 2013

Simbionix Releases Endovascular Basic Skills Training Module

Simbionix, Endovascular Basic Skills Training Module, endovascular simulator

September 18, 2013 – Simbionix USA Corp. released the Endovascular Basic Skills training module for the ANGIO Mentor simulator. The Simbionix ANGIO Mentor is a virtual-reality training simulator that provides hands-on practice in a simulated environment for endovascular procedures. An expanding library of modules supports the acquisition and honing of procedural skills to build confidence and proficiency in various endovascular techniques and procedures.

The Endovascular Basic Skills module is intended for residents or fellows who wish to acquire essential wire-catheter and imaging skills. It is set in a game-like environment and will allow training in a user friendly, enjoyable and safe setting. It allows physicians to learn and practice on both non-anatomical and anatomical vascular models in an interactive and challenging setting. This module is relevant for the following disciplines: vascular surgery, interventional radiology, interventional cardiology, interventional neuroradiology, neuro surgery, cardiothoracic surgery and trauma.

"The basic skills module allows us to teach the essential technical skills required across all endovascular intervention practice without compromising patient safety. It enables the resident or fellow to train independently in his free time, repeating the task as necessary to improve his assessment results. The teaching physician can then use the data provided by the system to assess the trainee and generate his learning curve over time, as well as compare him to a cohort of his peers," stated Jean Bismuth, M.D., assistant professor and vascular surgeon at the Houston’s Methodist DeBakey Heart and Vascular Center.

For more information: simbionix.com

 

Related Content

Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
Videos | Cath Lab | September 14, 2018
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS.
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Overlay Init